Facial Rejuvenation Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Topical Rejuvenation Products (Keratolytics, Moisturizers, Retinoids, Sunscreens, Hair Removals), Botulinum Products, (Dermal Fillers (Absorbable, Nonabsorbable), Chemical peels, Micro abrasion equipment, Equipment (Laser based equipment, Ultrasound-based equipment), By End-user (Hospitals, Dermatology clinics, Others) and Region Forecast 2020-2031

Facial Rejuvenation Market size was valued at US$ 27,767.5 million in 2024 and is expected to reach US$ 50,111.7 million by 2031, growing at a significant CAGR of 8.8% from 2025-2031. Facial rejuvenation is a combination of medical and cosmetic procedures that are carried out a youthful appearance to the human face. Facial rejuvenation is carried out by either minimally invasive or non-invasive treatment which aims to restore skin elasticity and enables maintaining a youthful appearance in the neck and face region. Facial rejuvenation plays a vital role in skin protection from sun damage. At young ages, human naturally defend their bodies from sun damage by neutralization free radicals which are reactive oxygen atoms that damage the skin's collagen.

However, human bodies lose their resistance to ultraviolet radiation in older age. The signs of sun damage include wrinkles, enlarged pores, sagging skin, freckling or spotting, and spider veins. Many treatments such as microabrasion, dermabrasion, topical creams, chemical peels, dermal fillers, and cosmetic surgery are available for the protection of skin from sun damage. Market players are adopting various key strategies that include acquisitions and mergers, collaborations, agreements, product approvals, and the launching of new products to increase share in the market.

Key Developments:

• In April 2016, Galderma Announced U.S. Collaboration in Aesthetics with Mentor Worldwide, LLC In March 2016, Merz received European approval for Bocouture used to treat upper facial lines
• In June 2009, Anika Therapeutics signed an exclusive U.S. distribution agreement with Palo Alto, Coapt Systems, Inc. for its aesthetic dermatology franchise. Coapt Systems' suite of bioabsorbable implants for use in facial aesthetic and rejuvenation procedures is highly complementary to Anika's injectable filler that corrects lines and wrinkles on the face. In addition,
• In July 2008, Johnson & Johnson received U.S. Food and Drug Administration clearance to market Evolence, an injectable collagen for treating facial wrinkles. Moreover,
• In April 2016, Merz Pharma made a strategic venture investment in Cytrellis Biosystems, for developing a new class of non-surgical products to combat sagging skin associated with aging.